FDA Inspection 738728 — Advanced Generic Corporation

Advanced Generic Corporation — FEI 3009054145

The FDA completed an inspection of Advanced Generic Corporation on Aug 1, 2011 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 1, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
113421 CFR 211.25(b)Supervisor Training/Education/Experience
1540221 CFR 111.12Personnel - quality control personnel - qualified
1592721 CFR 111.103Written procedures - quality control operations
1592821 CFR 111.103Written procedure quality control operations material review
256721 CFR 211.198(a)Adverse Drug Experience

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.